PennyProfits Alerts
About Us:
PennyProfits.com is an Internet based financial media service, which aggregates & distributes news and corporate developments within the micro-cap and penny stock markets. PennyProfits has a research database comprised of over 6,000 companies trading on the Pink Sheets® & OTCBB. We continue to expand our offerings through internal development, such as our Capsule Awareness Program (C.A.P.) and through external partnerships.
RESEARCH RESULTS
For Our Database of over 6,000 Penny Stocks
|
SCVM -
OTCBB Scivanta Medical Corp. 215 Morris Avenue Spring Lake, NJ 7762 PHONE: 732-282-1620 FAX: 732-282-1621 Industry: Medical Products & Equipment |
|
||||
|
|||||
Description: The Company acquired the exclusive world-wide rights to develop, manufacture and distribute certain proprietary technologies known as the Hickey Cardiac Monitoring System, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance. The HCMS will provide the primary measurements of cardiac performance, including left atrial pressure, which is a crucial measurement in monitoring cardiac challenged patients. The hardware, software and catheter components for the HCMS have been completed. Scivanta currently has a fully assembled HCMS device that has been used in initial clinical trials. The two major components remaining in the development of the HCMS are the completion of the clinical trials and the design and engineering of the production model of the HCMS. The Company conducted an initial clinical trial for the HCMS in Buffalo, New York at Kaleida Health/Millard Fillmore Hospital. This initial clinical trial commenced in October 2008 and was completed in March 2009. The Company successfully tested six patients during the initial clinical trial at Kaleida. Subject to the receipt of additional funding, the Company expects to test a minimum of 40 additional patients in clinical trials at Kaleida and at three other locations, all of which have been engaged. The Company will not be able to complete the clinical trials or the design and engineering of the production model of the HCMS without obtaining additional cash through an equity and/or debt financing or through corporate partnerships. The Company is aggressively pursuing potential investors and has engaged several placement agents to assist in this endeavor. Notes: formerly Medi-Hut Co., Inc. - MHUT Recent News Headlines: |
|||||
